Annual D&A
$16.73 M
+$6.34 M+61.09%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual depreciation & amortization is $16.73 million, with the most recent change of +$6.34 million (+61.09%) on December 31, 2023.
- During the last 3 years, DNLI annual D&A has risen by +$8.20 million (+96.06%).
- DNLI annual D&A is now at all-time high.
Performance
DNLI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.27 M
+$327.00 K+16.84%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly depreciation & amortization is $2.27 million, with the most recent change of +$327.00 thousand (+16.84%) on September 30, 2024.
- Over the past year, DNLI quarterly D&A has increased by +$327.00 thousand (+16.84%).
- DNLI quarterly D&A is now -77.42% below its all-time high of $10.05 million, reached on March 31, 2023.
Performance
DNLI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$8.55 M
+$52.00 K+0.61%
September 30, 2024
Summary
- As of February 7, 2025, DNLI TTM depreciation & amortization is $8.55 million, with the most recent change of +$52.00 thousand (+0.61%) on September 30, 2024.
- Over the past year, DNLI TTM D&A has increased by +$52.00 thousand (+0.61%).
- DNLI TTM D&A is now -54.13% below its all-time high of $18.64 million, reached on September 30, 2023.
Performance
DNLI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
DNLI Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.1% | +16.8% | +0.6% |
| 3 y3 years | +96.1% | -44.5% | -17.6% |
| 5 y5 years | +125.6% | -44.5% | -17.6% |
DNLI Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.7% | -77.4% | +16.8% | -54.1% | +2.0% |
| 5 y | 5-year | at high | +109.3% | -77.4% | +16.8% | -54.1% | +11.1% |
| alltime | all time | at high | >+9999.0% | -77.4% | +210.4% | -54.1% | +1069.6% |
Denali Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.27 M(+16.8%) | $8.55 M(+0.6%) |
| Jun 2024 | - | $1.94 M(-10.2%) | $8.50 M(-3.9%) |
| Mar 2024 | - | $2.16 M(-0.7%) | $8.84 M(-47.1%) |
| Dec 2023 | $16.73 M(+61.1%) | $2.18 M(-1.8%) | $16.73 M(-10.3%) |
| Sep 2023 | - | $2.22 M(-3.0%) | $18.64 M(+0.4%) |
| Jun 2023 | - | $2.29 M(-77.3%) | $18.56 M(+1.2%) |
| Mar 2023 | - | $10.05 M(+145.6%) | $18.35 M(+76.7%) |
| Dec 2022 | $10.38 M(+20.8%) | $4.09 M(+91.1%) | $10.38 M(+23.8%) |
| Sep 2022 | - | $2.14 M(+3.3%) | $8.39 M(-0.5%) |
| Jun 2022 | - | $2.07 M(-0.3%) | $8.43 M(-1.5%) |
| Mar 2022 | - | $2.08 M(-0.7%) | $8.56 M(-0.3%) |
| Dec 2021 | $8.59 M(+0.7%) | $2.09 M(-4.3%) | $8.59 M(-0.3%) |
| Sep 2021 | - | $2.19 M(-0.8%) | $8.62 M(+0.4%) |
| Jun 2021 | - | $2.20 M(+4.6%) | $8.59 M(+0.7%) |
| Mar 2021 | - | $2.11 M(-0.6%) | $8.53 M(-0.0%) |
| Dec 2020 | $8.53 M | $2.12 M(-1.6%) | $8.53 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $2.16 M(+0.5%) | $8.46 M(+3.2%) |
| Jun 2020 | - | $2.15 M(+1.7%) | $8.20 M(+6.5%) |
| Mar 2020 | - | $2.11 M(+2.6%) | $7.70 M(-3.7%) |
| Dec 2019 | $7.99 M(+7.8%) | $2.06 M(+8.7%) | $7.99 M(-3.9%) |
| Sep 2019 | - | $1.89 M(+15.0%) | $8.31 M(-5.0%) |
| Jun 2019 | - | $1.64 M(-31.6%) | $8.75 M(-2.4%) |
| Mar 2019 | - | $2.40 M(+1.0%) | $8.96 M(+20.9%) |
| Dec 2018 | $7.42 M(+140.6%) | $2.38 M(+2.2%) | $7.42 M(+26.9%) |
| Sep 2018 | - | $2.33 M(+25.4%) | $5.84 M(+36.1%) |
| Jun 2018 | - | $1.85 M(+117.2%) | $4.29 M(+34.0%) |
| Mar 2018 | - | $854.00 K(+5.8%) | $3.21 M(+4.0%) |
| Dec 2017 | $3.08 M(+109.8%) | $807.00 K(+3.7%) | $3.08 M(+35.5%) |
| Sep 2017 | - | $778.00 K(+1.6%) | $2.27 M(+52.0%) |
| Jun 2017 | - | $766.00 K(+4.8%) | $1.50 M(+104.8%) |
| Mar 2017 | - | $731.00 K | $731.00 K |
| Dec 2016 | $1.47 M(+1114.0%) | - | - |
| Dec 2015 | $121.00 K | - | - |
FAQ
- What is Denali Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Denali Therapeutics?
- What is Denali Therapeutics annual D&A year-on-year change?
- What is Denali Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Denali Therapeutics?
- What is Denali Therapeutics quarterly D&A year-on-year change?
- What is Denali Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Denali Therapeutics?
- What is Denali Therapeutics TTM D&A year-on-year change?
What is Denali Therapeutics annual depreciation & amortization?
The current annual D&A of DNLI is $16.73 M
What is the all time high annual D&A for Denali Therapeutics?
Denali Therapeutics all-time high annual depreciation & amortization is $16.73 M
What is Denali Therapeutics annual D&A year-on-year change?
Over the past year, DNLI annual depreciation & amortization has changed by +$6.34 M (+61.09%)
What is Denali Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of DNLI is $2.27 M
What is the all time high quarterly D&A for Denali Therapeutics?
Denali Therapeutics all-time high quarterly depreciation & amortization is $10.05 M
What is Denali Therapeutics quarterly D&A year-on-year change?
Over the past year, DNLI quarterly depreciation & amortization has changed by +$327.00 K (+16.84%)
What is Denali Therapeutics TTM depreciation & amortization?
The current TTM D&A of DNLI is $8.55 M
What is the all time high TTM D&A for Denali Therapeutics?
Denali Therapeutics all-time high TTM depreciation & amortization is $18.64 M
What is Denali Therapeutics TTM D&A year-on-year change?
Over the past year, DNLI TTM depreciation & amortization has changed by +$52.00 K (+0.61%)